Russians love Putin's dustup with the West. But they've stopped spending money
Why rival discounters are vying for control of Family Dollar Stores
Twitter's head of product, Daniel Graf, must make the service more user-friendly without offending hard-core fans
Yale's Robert Shiller is sending up warning flares. It may be best to ignore him
To minimize flood chaos, turn the hospital upside down
Bayer is marketing Berocca as performance drink, but Australians know what it's really for
After years of effort, top B-schools still enroll only about 40 percent female MBAs
Advice for a small bed-and-breakfast trying to get on the map for international tourists
Founders: Dr. Billy Hudson, Dr. Karl Tryggvason, and Dr. J. Wesley Fox
VC Investment over the last four quarters: $22 million
Founded in 2004, this eight-employee company develops innovative therapies for kidney disease. As for the recession, NephroGenex founders aren't daunted, and say that it will begin looking for a Big Pharma partner for its lead product next year.
Key to startup success: "If you are sure you have something that works and is useful to the marketplace, and others that you trust also agree, don't give up!"